About
About Hanmi Science Co., Ltd
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.
Visit company website
5 years, 5 months ago
Hanmi Science Co., Ltd is currently in a long term uptrend where the price is trading 23.6% above its 200 day moving average.
From a valuation standpoint, the stock is 48.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.
Hanmi Science Co., Ltd's total revenue rose by 0.0% to $219B since the same quarter in the previous year.
Its net income has increased by 100.1% to $16B since the same quarter in the previous year.
Finally, its free cash flow grew by 252.3% to $4B since the same quarter in the previous year.
Based on the above factors, Hanmi Science Co., Ltd gets an overall score of 5/5.